최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Korean journal of clinical laboratory science : KJCLS = 대한임상검사과학회지, v.50 no.2, 2018년, pp.155 - 163
신경아 (신성대학교 임상병리과)
Bilirubin has an anti-inflammatory effect as an endogenous antioxidant and has been reported to be inversely correlated with hypertension, diabetes, metabolic syndrome, and insulin resistance. On the other hand, there is a lack of research evaluating the association between bilirubin and metabolic s...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
대사증후군이란 무엇인가 | 대사증후군은 복부비만, 인슐린 저항성, 고혈압 및 이상지질 혈증이 함께 동반되는 질환으로 심혈관계 질환 및 제 2형 당뇨병의 위험 증가와 관련이 있다[1]. 대사증후군의 정확한 병태생리학적 특징은 여전히 불분명하다. | |
대사증후군을 유발하는 원인은 무엇인가? | 대사증후군의 정확한 병태생리학적 특징은 여전히 불분명하다. 인슐린 저항성, 아디포카인, 산화적 스트레스, 만성 염증 및 내피기능 장애와 같은 복잡한 병태생리학적 기전이 대사증후군을 유발하는 원인으로 제시되며, 이는 산화 스트레스와 밀접하게 관련되어 있다[1, 2]. | |
빌리루빈과 대사증후군과의 상관성은 특이적 효소와 비교해 어떤 상관성을 가지는가 | 본 연구에서 총 빌리루빈은 남녀 모두에서 복부비만, 중성지방과 역상관 관계를 보였으며, HDL-콜레스테롤과는 정적 상관성을 나타냈다. 그러나 이러한 상관성은 ALT 및 GGT와 같은 간 특이적 효소보다 약한 상관성이었다. 또한 남녀 모두에서 대사증후군 위험요인이 없는 군보다 대사증후군 진단군에서 간 효소치가 높았으며, 총 빌리루빈과 직접 빌리루빈치는 낮게 나타났다. |
Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705-712.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198:1-11.
Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006;184:431-437.
Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008;28:166-172.
Perlstein TS, Pande RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med. 2008;121:781-788.
Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes. 2008;57:1526-1535.
Jo J, Yun JE, Lee H, Kim H, Jee SH. Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population. Endocrine. 2011;39:182-189.
Li XH, Lin HY, Guan LY, Peng H, Wen MM, Cao YQ, et al. Direct bilirubin levels and risk of metabolic syndrome in healthy Chinese men. Biomed Res Int. 2017;2017:9621615.
Oda E, Aizawa Y. Total bilirubin is inversely associated with metabolic syndrome but not a risk factor for metabolic syndrome in Japanese men and women. Acta Diabetol. 2013;50:417-422.
Perera S, Lohsoonthorn V, Jiamjarasrangsi W, Lertmaharit S, Williams MA. Association between elevated liver enzymes and metabolic syndrome among Thai adults. Diabetes Metab Syndr. 2008;2:171-178.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
World Health Organization. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney, Australia: health communications Australia; 2000. p19-20.
Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996;51:859-862.
Guzek M, Jakubowski Z, Bandosz P, Wyrzykowski B, Smoczynski M, Jabloiska A, et al. Inverse association of serum bilirubin with metabolic syndrome and insulin resistance in Polish population. Przegl Epidemiol. 2012;66:495-501.
Wu Y, Li M, Xu M, Bi Y, Li X, Chen Y, et al. Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese. J Diabetes. 2011;3:217-224.
Lee MJ, Jung CH, Kang YM, Hwang JY, Jang JE, Leem J, et al. Serum bilirubin as a predictor of incident metabolic syndrome: a 4-year retrospective longitudinal study of 6205 initially healthy Korean men. Diabetes Metab. 2014;40:305-309.
Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005;25:1038-1044.
Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56:1535-1543.
Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:119-123.
Huang SS, Chan WL, Leu HB, Huang PH, Lin SJ, Chen JW. Serum bilirubin levels predict future development of metabolic syndrome in healthy middle-aged nonsmoking men. Am J Med. 2015;128:1138.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.